HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of adalimumab for the treatment of refractory paediatric acrodermatitis continua of hallopeau.

AuthorsValentina Dini, Sabrina Barbanera, Marco Romanelli
JournalActa dermato-venereologica (Acta Derm Venereol) Vol. 93 Issue 5 Pg. 588-9 (Sep 04 2013) ISSN: 1651-2057 [Electronic] Sweden
PMID23407925 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal, Humanized
  • Adalimumab
Topics
  • Acrodermatitis (diagnosis, drug therapy)
  • Adalimumab
  • Anti-Inflammatory Agents (therapeutic use)
  • Antibodies, Monoclonal, Humanized (therapeutic use)
  • Child
  • Female
  • Humans
  • Remission Induction
  • Skin (drug effects, pathology)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: